CompletedNot Applicable

Probiotic Supplementation as Prophylactic for Group B β-hemolytic Streptococcus (GBS) Infection

Italy250 participantsStarted 2019-01-01

Plain-language summary

Streptococcus agalactiae, a Group B β-hemolytic streptococcus (GBS), is the leading cause of severe neonatal infection in developed countries. There is growing scientific interest in probiotic supplementation in pregnancy as possible prophylaxis for GBS infections and urine culture positivity.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pregnant women in 24-36 weeks of gestation period * History of recurrent genitourinary and/or intestinal problems Exclusion Criteria: * Presence of neurological condition * History of cardiovascular disease * History of pulmonary disease * History of renal disease * Cancer

What they're measuring

Bacteriological assessment

Timeframe: 12 weeks

Bacteriological assessment

Timeframe: 12 weeks

Clinical assessments at the end of pregnancy

Timeframe: 12 weeks

Clinical assessments at the end of pregnancy

Timeframe: 12 weeks

Clinical assessments at the end of pregnancy

Timeframe: 12 weeks

clinical assessments at the end of pregnancy

Timeframe: 12 weeks

Clinical assessments at the end of pregnancy

Timeframe: 12 weeks

Trial details

NCT IDNCT06231056

SponsorLiaquat University of Medical & Health Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-12-31

View on ClinicalTrials.gov More Genitourinary; Infection, Complicating Pregnancy trials